Effects of early chemotherapeutic treatment on learning in adolescent mice: Implications for cognitive impairment and remediation in childhood cancer survivors

Clinical Cancer Research

Volumn 19, Issue 11, 2013, Pages 3008-3018

  Bisen Hersh, Emily B ^a   Hineline, Philip N ^a   Walker, Ellen A ^a,b  

^a TEMPLE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; METHOTREXATE; SODIUM CHLORIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVOR; CHILDHOOD CANCER; COGNITIVE DEFECT; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG MEGADOSE; EARLY INTERVENTION; FEMALE; HUMAN; LEARNING; MEMORY; MENTAL TASK; MONOTHERAPY; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RECOGNITION; SEX DIFFERENCE; TRAINING; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FEMALE; HUMANS; LEARNING; MALE; METHOTREXATE; MICE; MILD COGNITIVE IMPAIRMENT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREGNANCY; SURVIVORS;

EID: 84878995269     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3764     Document Type: Article

References (54)

1. Pui C, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166-78. (Pubitemid 43076714)
2. Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006;24:3858-64. (Pubitemid 46630732)
3. Waber DP, Turek J, Catania L, Stevenson K, Robaey P, Romero I, et al. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber cancer institute ALL consortium protocol 95-01. J Clin Oncol 2007;25:4914-21. (Pubitemid 350220422)
4. Krull KR, Okcu MF, Potter B, Jain N, Dreyer Z, Kamdar K, et al. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol 2008;26:4138-43.
5. Buizer AI, de Sonneville LMJ, Veerman AJP. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer 2009;52:447-54.
6. Reddick WE, Conklin HM. Impact of acute lymphoblastic leukemia therapy on attention and working memory in children. Expert Rev Hematol 2010;3:655-9.
7. Seigers R, Fardell JE. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 2011;35:729-41.
8. Li Y, Vijayanathan V, Gulinello ME, Cole PD. Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats. Pharmacol Biochem Behav 2010;94:454-63.
9. Yadin E, Bruno L, Micalizzi M, Rorke L, D'Angio G. An animal model to detect learning deficits following treatment of the immature brain. Childs Brain 1983;10:273-80. (Pubitemid 13002068)
10. Yanovski JA, Packer RJ, Levine JD, Davidson TL, Micalizzi M, D'Angio G. An animal model to detect the neuropsychological toxicity of anticancer agents. Med Pediatr Oncol 1989;17:216-21. (Pubitemid 19187090)
11. Mullenix PJ, Kernan WJ, Schunior A, Howes A, Waber DP, Sallan SE, et al. Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia. Pediatr Res 1994;35:171-8. (Pubitemid 24039144)
12. Stock HS, Rosellini RA, Abrahamsen GC, McCaffrey RJ, Ruckdeschel JC. Methotrexate does not interfere with an appetitive pavlovian conditioning task in Sprague-Dawley rats. Physiol Behav 1995;58:969-73.
13. Gregorios JB, Gregorios AB, Mora J, Marcillo A, Fojaco RM, Green B. Morphologic alterations in rat brain following systemic and intraventricular methotrexate injection: light and electron microscopic studies. J Neuropathol Exp Neurol 1989;48:33-47. (Pubitemid 19018680)
14. Vezmar S,Becker A,BodeU, Jaehde U. Biochemicalandclinical aspects of methotrexate neurotoxicity. Chemotherapy 2003;49:92-104. (Pubitemid 36469805)
15. Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, et al. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 2008;186:168-75. (Pubitemid 350122748)
16. Seigers R, Pourtau L, Schagen SB, van Dam FS, Koolhaas JM, Konsman JP, et al. Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Res Bull 2010;81:472-6.
17. Madhyastha S, Somayaji SN, Rao MS, Nalini K, Bairy KL. Hippocampal brain amines in methotrexate-induced learning and memory deficit. Can J Physiol Pharmacol 2002;80:1076-84. (Pubitemid 36002665)
18. Foley JJ, Raffa RB, Walker EA. Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology (Berl) 2008;199:527-38.
19. Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 2006;5:22.
20. Li CQ, Liu D, Huang L, Wang H, Zhang JY, Luo XG. Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats. Brain Res Bull 2008;77:237-40.
21. Filley CM. Toxic leukoencephalopathy. Clin Neuropharmacol 1999;22:249-60. (Pubitemid 29506393)
22. Akutsu M, Furukawa Y, Tsunoda S, Izumi T, Ohmine K, Kano Y. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro . Leukemia 2002;16:1808-17.
23. Vanover KE, Barrett JE. An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response. Behav Pharmacol 1998;9:273-83. (Pubitemid 28273113)
24. Barrett JE, Vanover KE. Assessment of learning and memory using the autoshaping of operant responding in mice. Curr Protoc Neurosci 2004;Chapter 8:Unit 8.5F.
25. Dudchenko PA. An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev 2004;28:699-709. (Pubitemid 39535867)
26. Dunn MJ, Futter D, Bonardi C, Killcross S. Attenuation of d-amphetamine-induced disruption of conditional discrimination performance by α-flupenthixol. Psychopharmacology (Berl) 2005;177:296-306. (Pubitemid 40137290)
27. Schrier AM, Thompson CR. Conditional discrimination learning: a critique and amplification. J Exp Anal Behav 1980;33:291-8. (Pubitemid 10067514)
28. Klinkenberg I, Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 2010;34:1307-50.
29. Laviola G, Macri S, Morley-Fletcher S, Adriani W. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 2003;27:19-31. (Pubitemid 36535388)
30. Boxenbaum H. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 1982;10:201-27. (Pubitemid 12044187)
31. Tang H, Mayersohn M. A mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance. Drug Metab Dispos 2005;33:1294-6. (Pubitemid 41196971)
32. Davenport JW. Combined autoshaping-operant (AO) training: CSUCS interval in rats. Bull Psychomonic Soc 1974;3:383-5.
33. Sik A, van Nieuwehuyzen P, Prickaerts J, Blokland A. Performance of different mouse strains in an object recognition task. Behav Brain Res 2003;147:49-54. (Pubitemid 37491412)
34. Mathiasen JR, Dicamillo A. Novel object recognition in the rat: a facile assay for cognitive function. Curr Protoc Pharmacol 2010;Chapter 5: Unit 5.59.
35. Dix S, Gilmour G, Potts S, Smith JW, Tricklebank M. A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists. Psychopharmacology (Berl) 2010;212:227-42.
36. Palmer SL, Goloubeva O, Reddick WE, Glass JO, Gajjar A, Kun L, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J Clin Oncol 2001;19:2302-8. (Pubitemid 32366983)
37. Ashford J, Schoffstall C, Reddick WE, Leone C, Laningham FH, Glass JO, et al. Attention and working memory abilities in children treated for acute lymphoblastic leukemia. Cancer 2010;116:4638-45.
38. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsych 2000;15:603-630.
39. Bisen-Hersh EB, Hineline PN, Walker EA. Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models. J Cancer 2011;2:292-301.
40. Walker EA. Animal models of chemotherapy-induced learning and memory deficits. In: Raffa RB, Tallarida RJ, editors. 'Chemofog': cognitive deficits associated with cancer chemotherapy. Austin (TX): RG Landes Bioscience, Inc.; 2010.
41. Walker EA, Foley JJ, Clark-Vetri R, Raffa RB. Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl) 2011;217:539-48.
42. Winocur G, Vardy J, Binns MA, Kerr L, Tannock I. The effects of the anticancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 2006;85:66-75. (Pubitemid 44802737)
43. Winocur G, Henkelman M, Wojtowicz JM, Zhang H, Binns MA, Tannock IF. The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res 2012;18:3112-21.
44. Winneke G, Brockhaus A, Baltissen R. Neurobehavioral and systemic effects of longterm blood lead-elevation in rats. I. Discrimination learning and open field-behavior. Arch Toxicol 1977;37:247-63. (Pubitemid 8245973)
45. van Praag H, Mei Qu P, Elliott RC, Wu H, Dreyfus CF, Black IB. Unilateral hippocampal lesions in newborn and adult rats: effects on spatial memory and BDNF gene expression. Behav Brain Res 1998;92:21-30. (Pubitemid 28179604)
46. Rayen I, van den Hove DL, Prickaerts J, Steinbusch HW, Pawluski JL. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS ONE 2011;6:e24003.
47. Boyette-Davis JA, FuchsPN. Differential effects of paclitaxel treatment on cognitive functioning and mechanical sensitivity. Neurosci Lett 2009;453:170-4.
48. Butler RW. Attentional processes and their remediation in childhood cancer. Med Pediatr Oncol 1998;Suppl 1:75-8.
49. Butler RW, Copeland DR. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 2002;8:115-24. (Pubitemid 34130479)
50. Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008;76:367-78. (Pubitemid 351822338)
51. Reid LS. The development of non-continuity behavior through continuity learning. J Exp Psychol 1953;46:107-12.
52. Mayer LD, Janoff AS. Optimizing combination chemotherapy by controlling drug ratios. Mol Interv 2007;7:216-23. (Pubitemid 47437268)
53. Kato I, Niwa A, Heike T, Fujino H, Saito MK, Umeda K, et al. Identification of hepatic niche harboring human acute lymphoblastic leukemia cells via the SDF-1/CXCR4 axis. PLoS ONE 2011;6:e27042.
54. Ito R, Takahashi T, Katano I, Ito M. Current advances in humanized mouse models. Cell Mol Immunol 2012;9:208-14.